ANSM
- Local brand name: Iqirvo
- Status: approved
Iqirvo (ELAFIBRANOR) regulatory status in France.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. ANSM has authorised it.
Ipsen is the originator. The local marketing authorisation holder may differ — check the official source linked above.